Loading…
Glut-1 Translocation in FRTL-5 Thyroid Cells: Role of Phosphatidylinositol 3-Kinase and N-Glycosylation
It was previously demonstrated that insulin or TSH treatment of FRTL-5 cells resulted in an elevation of glucose transport and in an increase of cell surface expression of the glucose transporter Glut-1. However, the signaling mechanisms leading to the insulin or TSH-induced increase in the cell sur...
Saved in:
Published in: | Endocrinology (Philadelphia) 2000-11, Vol.141 (11), p.4146-4155 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | It was previously demonstrated that insulin or TSH treatment of FRTL-5
cells resulted in an elevation of glucose transport and in an increase
of cell surface expression of the glucose transporter Glut-1. However,
the signaling mechanisms leading to the insulin or TSH-induced increase
in the cell surface expression of Glut-1 were not investigated. In the
present study, we demonstrated that wortmannin and LY294002, two
specific inhibitors of phosphatidylinositol 3-kinase (PI3-kinase),
interfere both in the signaling pathways of insulin and TSH leading to
glucose consumption enhancement and Glut-1 translocation. Two hours
after insulin treatment, TSH or cAMP analog (Bu)2cAMP
stimulation, glucose transport was increased and most of the
intracellular Glut-1 pool was translocated to plasma membranes.
Wortmannin or LY294002 blocked the insulin, (Bu)2cAMP, and
the TSH-induced translocation of Glut-1. Wortmannin or LY294002 alone
did not alter the basal ratio between intracellular and cell surface
Glut-1 molecules. These results suggest that in FRTL-5 cells wortmannin
and LY294002 inhibited the insulin, (Bu)2cAMP and TSH
events leading to Glut-1 translocation from an intracellular
compartment to the plasma membrane. Likewise, (Bu)2cAMP
effects on glucose transport and Glut-1 translocation to plasma
membrane were repressed by PI3-kinase inhibitors but not by the protein
kinase A (PKA) inhibitor H89. We suggest that (Bu)2cAMP
stimulates Glut-1 translocation to plasma membrane through
PI3-kinase-dependent and PKA-independent signaling pathways. To further
elucidate mechanisms that regulate the translocation of Glut-1 to cell
membrane, we extended this study to the role played by the
N-glycosylation in the translocation and in the
biological activity of Glut-1 in FRTL-5 cells. For this purpose we used
tunicamycin, an inhibitor of the N-glycosylation. Our
experiments with tunicamycin clearly showed that both the glycosylated
and unglycosylated forms of the transporter reached the cell surface.
Likewise, a decrease in glucose consumption (−50%) after treatment of
cells with tunicamycin was accompanied by a decrease (−70%
vs. control) in the membrane expression of a 50-kDa form
of Glut-1 and an increase in its unglycosylated 41-kDa form. These
results suggest that carbohydrate moiety is essential for the
biological activity of glucose transport but is not required for the
translocation of Glut-1 from the intracellular membrane pool to the
plasma membrane. |
---|---|
ISSN: | 0013-7227 1945-7170 |
DOI: | 10.1210/endo.141.11.7793 |